Aakaar Medical Technologies IPO Review

Aakaar Medical Technologies are a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. The product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria.

The company is Promoted by DILIP RAMESH MESWANI possesses over 24 years of experience and BINDI DILIP MESWANI possesses over 10 years of experience in the fields of Medical Aesthetics.

The Revenues from operations for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹  6,176.07 Lakh, ₹ 4,627.04 Lakh and ₹ 3,287.85 Lakh. The EBITDA for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 991.48 Lakh, ₹ 515.83 Lakh and ₹ 362.25 Lakh. The Profit after Tax for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 603.95 Lakh, ₹ 287.02 Lakh and ₹ 215.32 Lakh respectively. This indicates a steady growth in financial performance

The Company Key Performance Indicates the pre-issue EPS of ₹ 6.13 and post-issue EPS of ₹ 4.26 for FY24. The pre-issue P/E ratio is 11.74x, while the post-issue P/E ratio is 16.90x. The company's ROCE for FY24 is 21.02%, ROE for FY24 is 33.81% and RoNW is 33.81%. These metrics suggest that the IPO is fairly priced.

The Grey Market Premium (GMP) of Aakaar Medical Technologies showing listing gains of 0.00 %.Given the company's financial performance and the valuation of the IPO, we recommend Investors to Avoid to the Aakaar Medical Technologies Limited IPO for Listing gain.

Disclaimer: The information provided in this IPO review is for educational and informational purposes only and should not be construed as financial advice or an offer to buy or sell securities. The review must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. The content is based on publicly available information and market perceptions as of the date of publication and is subject to change. Neither the author nor the website is responsible for any losses or damages arising from the use of this information. 1.“Registration granted by SEBI, membership of a SEBI recognized supervisory body (if any) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.” 2. “Investment in securities market are subject to market risks. Read all the related documents carefully before investing.” 3. To read the Disclaime

rs, Disclosures, Investor Charter, Investor Complaints please visit our website abhayvarn.com

About the Author
CA Abhay Kumar (Also known as  CA Abhay Varn) is a qualified Chartered Accountant by profession and cleared CA at age 21. He is a SEBI Registered Research Analyst with Registration Number - INH300008465. He Possesses 8+ years of experience in the Stock Market Field and has also worked in Big CA firms.